Table 2.
Laboratory code | Bioactivity | Target cell line | Source of Complement | Ratio E:Ta | Assay Type | Assay duration (h)b | In house reference standard | Assay read out (reagent) |
---|---|---|---|---|---|---|---|---|
1 | CDCc | WIL2-S | Human | N/Ad | Viability | 18 | Yes | Fluorescence (Alamar Blue) |
ADCCe | WIL2-S | N/A | 6 | Reporter gene | 6 | Yes | Luminescence (Luciferase) | |
2 | CDC | WIL2-S | Human | N/A | Viability | 18 | – | Fluorescence (Alamar Blue) |
3 | CDC | WIL2-S | Human | N/A | Viability | 20 ± 4 | Yes | Fluorescence (Alamar Blue) |
4 | CDC | WIL2-S | Human | N/A | Viability | 18 | – | Fluorescence (Alamar Blue) |
5 | CDC | WIL2-S | Rabbit | N/A | Viability | 18 ± 2 | Yes | Fluorescence (Alamar Blue) |
6 | CDC | Raji | Rabbit | N/A | Viability | 2 | Yes | Luminescence (Cell-titre Glo) |
ADCC | Raji | N/A | 19 | NK cell line Killing | 1 | Yes | Fluorescence (Calcein AM release) | |
Binding | Raji | N/A | N/A | Competition binding | ∼1 | Yes | Fluorescence (FACs) | |
Apoptosis | Z-138 | N/A | N/A | Apoptosis | 24 ± 1 | Yes | Fluorescence (Annexin-V by FACS) | |
7 | CDC | WIL2-S | Human | N/A | Viability | 6 | Yes | Colorimetric (MTS) |
ADCC | WIL2-S | N/A | 7.6 | Reporter gene | 19 | Yes | Luminescence (Luciferase) | |
8 | CDC | Raji | Human | N/A | Viability | 7 | Yes | Colorimetric (CCK-8) |
ADCC | WIL2-S | N/A | 5 | Reporter gene | 6 | Yes | Luminescence (Luciferase) | |
Binding | Raji | N/A | N/A | Binding | 0.5 | Yes | Fluorescence (2ry Ab detection by FACS) | |
9 | CDC | Raji | Human | N/A | Toxicity | 5 | Yes | Colorimetric (LDH) |
10 | CDC | WIL2-S | Human | N/A | Viability | 4–4.5 | Yes | Colorimetric (CCK-8) |
ADCC | Raji | N/A | 1 | NK cell line Killing | 2.5 | Yes | Colorimetric (LDH) | |
Binding | WIL2-S | N/A | N/A | Binding | 1–1.5 | Yes | Colorimetric (2ry Ab detection) | |
11 | CDC | WIL2-S | Rabbit | N/A | Viability | 2 | Yes | Fluorescence (Alamar Blue) |
ADCC | WIL2-S | N/A | 5:1 | PBMC based Killing | 4 | – | Fluorescence (Cyto-tox reagent) | |
12 | CDC | Daudi | Human | N/A | Toxicity | 2 | Yes | Luminescence (Cell-titre Glo) |
ADCC | Daudi | N/A | 5 | Reporter gene | 4 | Yes | Luminescence (Luciferase) | |
Binding | Daudi | N/A | N/A | Binding | 0.5 | Yes | Fluorescence (2ry Ab detection by FACS) | |
13 | CDC | WIL2-S | Rabbit | N/A | Toxicity | 1 | Yes | Fluorescence (Calcein AM release) |
ADCC | WIL2-S | N/A | 25 | NK cell line Killing | 1 | Yes | Fluorescence (Calcein AM release) | |
14 | CDC | Jeko | Rabbit | N/A | Viability | 2 | – | Luminescence (Cell-titre Glo) |
ADCC | Jeko | N/A | 8 | Primary NK cell Killingb | 18–22 | – | Luminescence (Cyto-tox Glo) | |
15 | CDC | WIL2-S | Human | N/A | Viability | 2 | Yes | Colorimetric (CCK-8) |
ADCC | Raji | N/A | 16 | PBMC based Killingb | 4 | Yes | Fluorescence (Calcein AM release) | |
16 | CDC | WIL2-S | Human | N/A | Viability | 18 | Yes | Fluorescence (Alamar Blue) |
ADCC | WIL2-S | N/A | 8 | Dual-reporter gene | 18 | – | Luminescence (Firefly & Renilla Luciferase) | |
Binding | WIL2-S | N/A | N/A | Binding | 1 | Yes | Fluorescence (2ry Ab detection by FACS) |
E:T- effector: target cell ratio;
(h) hours;
CDC: Complement-dependent cytotoxicity;
N/A: non-applicable;
ADCC: Antibody-dependent cell-mediated cytotoxicity.